You searched for Innovation

We found for

Insight
February 2023

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

Fishing on the lake at sunset. Fishing background.

Insight
February 2023

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

News
January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Insight
December 2022

G7 Investments in New Antibiotics Would Pay Off – For Everyone

Insight
October 2022

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

US-Drug-Pricing_Adobe_Снежана-Кудрявцева-scaled-1

Insight
June 2022

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

Insight
March 2022

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.

Insight
February 2022

Rare Disease Day 2022

Insight
February 2022

How Does Pharmaceutical Spending Drive Innovation in Europe?

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Insight
April 2021

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Insight
March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

Payment Models for Multi-Indication Therapies

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

News & Insights

Latest Research & Publications

All Publications

We found for

Filter results by

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

G7 Investments in New Antibiotics Would Pay Off – For Everyone

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.

Rare Disease Day 2022

How Does Pharmaceutical Spending Drive Innovation in Europe?

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Would Waiving COVID-19 Vaccines Patents Save Lives?

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Does Government Funding Increase Public Sector Development of New Medicines?

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

Payment Models for Multi-Indication Therapies

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making